Loading...
Loading...
Browse all stories on DeepNewz
VisitHow many atoms will AI models simulate with quantum accuracy by November 2025?
Up to 100,000 atoms • 25%
100,001 to 200,000 atoms • 25%
200,001 to 300,000 atoms • 25%
More than 300,000 atoms • 25%
Scientific publications or announcements from leading research institutions
AI2BMD by Microsoft Research Transforming Biomedical Research and Drug Discovery
Nov 8, 2024, 02:00 PM
Recent advancements in artificial intelligence (AI) are revolutionizing the field of biomedical research and drug discovery. Microsoft Research has developed an AI model, AI2BMD, that can simulate proteins with more than 10,000 atoms with quantum accuracy, significantly faster than previous methods. Published in Nature, the results of AI2BMD align closely with wet-lab experiments, paving the way for new biomedical research breakthroughs. Additionally, companies like AbSci are leveraging AI to create drug candidates for previously unreachable targets, streamlining therapy development and reducing costs. SeanRMcClain and Andreas Busch of AbSci have highlighted these innovations. AI's capabilities are also challenging the role of quantum computing in complex simulations, with AI now able to simulate systems up to 100,000 atoms. These advancements highlight the transformative potential of AI in the fields of chemistry, materials science, and pharmaceuticals.
View original story
Less than 50 • 25%
50 to 100 • 25%
101 to 150 • 25%
More than 150 • 25%
150-200 Qubits • 25%
201-300 Qubits • 25%
301-500 Qubits • 25%
Over 500 Qubits • 25%
Yes • 50%
No • 50%
IBM • 25%
Google • 25%
Microsoft • 25%
Other • 25%
Less than 20 • 25%
20-29 • 25%
30-39 • 25%
40 or more • 25%
Integration into commercial quantum processors • 25%
Demonstration of error correction on a new quantum processor • 25%
Partnership with a major tech company • 25%
Other • 25%
Less than 200 qubits • 25%
200 to 500 qubits • 25%
501 to 1000 qubits • 25%
More than 1000 qubits • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
No • 50%
Yes • 50%
Increased collaboration with AI companies • 25%
Significant cost reduction • 25%
All of the above • 25%
Faster drug development • 25%